volume 21 issue 8 publication number e15734072329263

4-methyl-N-[5-[Phenylamino]Acetyl]-2-yl]Benzenesulfonamides: Synthesis, Characterization, and Preliminary Biological Evaluation

Himachal Sharma 1
Atul Pratap Singh 1
Jiya ul Hak 1
Divya Pathak 1
Dhananjay Taumar 1
Anshu Gujjar 1
Vatan Chaudhary 1
Iram Jahan 1
1
 
Department of Pharmaceutical Chemistry, IIMT College of Medical Sciences, IIMT University, Meerut, India
Publication typeJournal Article
Publication date2025-10-01
scimago Q2
SJR0.287
CiteScore1.8
Impact factor
ISSN15734072
Abstract
Introduction:

Oxazole and the compounds containing sulphonamides are utilized for various treatments of microbial disease as well as for diabetic patients. In the current study, the above moiety synthesizes the new molecule for the treatment of diabetes and microbial infection. The present work involved oxazole-based sulphonamide derivatives by the N-acylation and N-sulphonation. The synthesis was carried out by treating substituted anilines with chloroacetic chloride. The cycloaddition reaction was carried out using triethyl amine as a base catalyst. In the final steps, toluene sulphonyl chloride was used for sulphonation. The synthesized substance was confirmed via IR, 1H NMR, ESI, Mass spectroscopy, and elemental investigation technique.

Material and Methods:

Every reagent and starting material used in the synthesis was pure enough to be used as a reagent. To provide an inert environment, the solvents were purified in accordance with conventional laboratory protocols under a nitrogen atmosphere. Melting points are expressed in degrees Celsius and are uncorrected. They were determined by the open capillary technique. KBr pellets and a Shimadzu 8201 PC FTIR spectrophotometer were used to obtain FTIR spectra. Using JEOL and Bruker 500 MHz NMR spectrometers, ~1H and ~13C NMR spectra were obtained in CDCl3 and DMSO-d6, with TMS serving as the internal reference. A Thermo- Finnigan mass spectrophotometer was used to determine the masses of the chemical using the ESI technique.

Results:

The present work involved oxazole-based sulphonamides derivatives by the N-acylation and N-sulphonation. The synthesis was carried out by treating substituted anilines with chloroacetic chloride. The cycloaddition reaction was carried out using triethyl amine as a base catalyst. In the final steps, toluene sulphonyl chloride was used for sulphonation. IR, 1HNMR, ESI, Mass spectroscopy and elemental analysis technique confirmed the synthesized compound.

Discussion:

Oxazoles are also related to compounds called 1,3-azoles[nitrogen and oxygen heteroatoms in a 5-membered ring]. Oxazole demonstrates aromaticity since Huckel's rule requires 6π electrons, which are provided by the delocalization of a single pair of electrons from the oxygen atom. It has a wide range of pharmacological aspects like anti-allergic, hypertension, inflammation, schizophrenia, and inflammation. Similarly, sulphonamides are also used as preventive and chemotherapeutic agents against various diseases such as antibacterial, antiprotozoal, antifungal, and translation initiation inhibitors.

Conclusion:

The preliminary biological activity was performed on a preliminary level for the antimicrobial and antidiabetic profile. The disc diffusion approach was utilized to achieve the antibacterial activity; similarly diabetic activity was carried out by the induced method. Out of all the synthesized compounds N-[5-[2-[4-bromophenyl amino]acetyloxazole2 yl]-4methylo benzene sulphonamide [4a], N-[5-2[2-FLoro-5nitrophenyl amino]acetyloxazole2yl]-4methylo benzene sulfonamide [4b] show significant effect compared to standard drugs.

Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Share
Cite this
GOST |
Cite this
GOST Copy
Sharma H. et al. 4-methyl-N-[5-[Phenylamino]Acetyl]-2-yl]Benzenesulfonamides: Synthesis, Characterization, and Preliminary Biological Evaluation // Current Bioactive Compounds. 2025. Vol. 21. No. 8. e15734072329263
GOST all authors (up to 50) Copy
Sharma H., Singh A. P., Hak J. U., Pathak D., Taumar D., Gujjar A., Chaudhary V., Jahan I. 4-methyl-N-[5-[Phenylamino]Acetyl]-2-yl]Benzenesulfonamides: Synthesis, Characterization, and Preliminary Biological Evaluation // Current Bioactive Compounds. 2025. Vol. 21. No. 8. e15734072329263
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2174/0115734072329263241009051355
UR - https://www.eurekaselect.com/235407/article
TI - 4-methyl-N-[5-[Phenylamino]Acetyl]-2-yl]Benzenesulfonamides: Synthesis, Characterization, and Preliminary Biological Evaluation
T2 - Current Bioactive Compounds
AU - Sharma, Himachal
AU - Singh, Atul Pratap
AU - Hak, Jiya ul
AU - Pathak, Divya
AU - Taumar, Dhananjay
AU - Gujjar, Anshu
AU - Chaudhary, Vatan
AU - Jahan, Iram
PY - 2025
DA - 2025/10/01
PB - Bentham Science Publishers Ltd.
IS - 8
VL - 21
SN - 1573-4072
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Sharma,
author = {Himachal Sharma and Atul Pratap Singh and Jiya ul Hak and Divya Pathak and Dhananjay Taumar and Anshu Gujjar and Vatan Chaudhary and Iram Jahan},
title = {4-methyl-N-[5-[Phenylamino]Acetyl]-2-yl]Benzenesulfonamides: Synthesis, Characterization, and Preliminary Biological Evaluation},
journal = {Current Bioactive Compounds},
year = {2025},
volume = {21},
publisher = {Bentham Science Publishers Ltd.},
month = {oct},
url = {https://www.eurekaselect.com/235407/article},
number = {8},
pages = {e15734072329263},
doi = {10.2174/0115734072329263241009051355}
}